An Empirically Derived Pediatric Cardiac Inotrope Score Associated With Pediatric Heart Surgery

Punkaj Gupta1, Mallikarjuna Rettiganti2, Andrew Wilcox1

  • 1Division of Pediatric Cardiology, Department of Pediatrics, University of Arkansas for Medical Sciences, College of Medicine, Arkansas Children's Hospital, Little Rock, Arkansas.

Insights

A new pediatric cardiac inotrope score (PCIS) predicts outcomes after heart surgery using inotrope doses. This tool helps assess mortality and hospital stay in children undergoing cardiac operations.

Area of Science:

  • Pediatric Cardiology
  • Critical Care Medicine
  • Pharmacometrics

Background:

  • Predicting outcomes in pediatric cardiac surgery patients is challenging.
  • Inotrope management is critical for hemodynamic support post-cardiac operations.
  • A validated scoring system for inotrope use is lacking in this population.

Purpose of the Study:

  • To empirically derive and validate a novel pediatric cardiac inotrope score (PCIS).
  • To predict real-time outcomes including in-hospital mortality and prolonged length of stay.
  • To utilize inotrope doses administered within 24 hours post-operation for outcome prediction.

Main Methods:

  • Data from 1030 pediatric patients (<18 years) undergoing cardiac surgery were analyzed.
  • A hierarchical framework with Bayesian conditional probit regression was employed.
  • Markov chain Monte Carlo simulations were used to develop the PCIS and outcome prediction models.

Main Results:

  • The developed PCIS demonstrated high discrimination for predicting in-hospital mortality and prolonged hospital stay.
  • The score effectively integrated doses of epinephrine, norepinephrine, dopamine, and milrinone.
  • An online calculator is available for clinical application of the PCIS.

Conclusions:

  • The novel empiric PCIS is a valuable tool for predicting real-time outcomes in pediatric cardiac surgery.
  • PCIS provides a quantitative measure to guide management and prognosticate based on inotrope administration.
  • This score is applicable to children undergoing cardiac operations of varying complexity.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
281
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.6K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
334
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
256
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
318
Physiology of the Heart: The Cardiac Cycle01:18

Physiology of the Heart: The Cardiac Cycle

The cardiac cycle describes the events from one heartbeat to the next. It includes three main phases: diastole, atrial systole, and ventricular systole, all driven by changes in chamber pressures and the function of heart valves.
Diastole: The Relaxation Phase
During diastole, all four heart chambers relax. The atrioventricular (AV) valves open, and the semilunar valves close. This phase sees the lowest chamber pressures, promoting ventricular filling. Venous blood enters the heart through the...
10.2K